261 related articles for article (PubMed ID: 22318291)
1. Measurement of antifungal drug levels in cerebrospinal fluid for cryptococcal meningoencephalitis.
Shoji H; Takuma T; Ohbayashi H; Yoshida K; Yamamoto T; Niki Y
J Infect Chemother; 2012 Oct; 18(5):775-9. PubMed ID: 22318291
[TBL] [Abstract][Full Text] [Related]
2. Relationship between intracranial pressure and antifungal agents levels in the CSF of patients with cryptococcal meningitis.
Wirth F; de Azevedo MI; Pilla C; Aquino VR; Neto GW; Goldani LZ
Med Mycol; 2018 Apr; 56(3):257-262. PubMed ID: 28992308
[TBL] [Abstract][Full Text] [Related]
3. [Cryptococcal meningitis successfully treated with liposomal amphotericin B and voriconazole in an elderly patient].
Ogaki K; Noda K; Fukae J; Furuya T; Hirayama T; Fujishima K; Hattori N; Okuma Y
Brain Nerve; 2010 Dec; 62(12):1337-40. PubMed ID: 21139187
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment with voriconazole combined with amphotericin B-liposome for fluconazole-resistant pulmonary cryptococcosis after renal transplantation.
Fujioka K; Nagai T; Kinoshita Y; Urushihara M; Hamasaki Y; Shishido S; Kagami S
CEN Case Rep; 2019 Nov; 8(4):261-265. PubMed ID: 31161376
[TBL] [Abstract][Full Text] [Related]
5. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.
Brouwer AE; Rajanuwong A; Chierakul W; Griffin GE; Larsen RA; White NJ; Harrison TS
Lancet; 2004 May; 363(9423):1764-7. PubMed ID: 15172774
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
Sloan D; Dlamini S; Paul N; Dedicoat M
Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
[TBL] [Abstract][Full Text] [Related]
7. Case report: a special case of cryptococcal infection-related inflammatory syndrome in a non-HIV infected and non-transplant patient.
Su XH; Li WP; Lin Q; Zheng XJ; Fang T; Jiang Y; Peng FH
BMC Neurol; 2022 Jul; 22(1):247. PubMed ID: 35794548
[TBL] [Abstract][Full Text] [Related]
8. New guinea pig model of Cryptococcal meningitis.
Kirkpatrick WR; Najvar LK; Bocanegra R; Patterson TF; Graybill JR
Antimicrob Agents Chemother; 2007 Aug; 51(8):3011-3. PubMed ID: 17562797
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis.
Loyse A; Wilson D; Meintjes G; Jarvis JN; Bicanic T; Bishop L; Rebe K; Williams A; Jaffar S; Bekker LG; Wood R; Harrison TS
Clin Infect Dis; 2012 Jan; 54(1):121-8. PubMed ID: 22052885
[TBL] [Abstract][Full Text] [Related]
10. Liposomal amphotericin B for a case of intractable cryptococcal meningoencephalitis and immune reconstitution syndrome.
Sasakawa A; Yamamoto Y; Yajima K; Sakai M; Uehira T; Shirasaka T; Makie T
J Med Invest; 2008 Aug; 55(3-4):292-6. PubMed ID: 18797146
[TBL] [Abstract][Full Text] [Related]
11. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
Trpković A; Pekmezović M; Barać A; Crnčević Radović L; Arsić Arsenijević V
J Mycol Med; 2012 Sep; 22(3):243-8. PubMed ID: 23518082
[TBL] [Abstract][Full Text] [Related]
12. Triple therapy versus amphotericin B plus flucytosine for the treatment of non-HIV- and non-transplant-associated cryptococcal meningitis: retrospective cohort study.
Xu L; Liu J; Zhang Q; Li M; Liao J; Kuang W; Zhu C; Yi H; Peng F
Neurol Res; 2018 May; 40(5):398-404. PubMed ID: 29560802
[TBL] [Abstract][Full Text] [Related]
13. [Intraventricular cryptococcoma successfully treated with liposomal amphotericin B and voriconazole: a case report].
Inoue A; Harada H; Iwata S; Teraoka M; Yamashita D; Kumon Y; Ohnishi T
No Shinkei Geka; 2012 Sep; 40(9):777-84. PubMed ID: 22915699
[TBL] [Abstract][Full Text] [Related]
14. Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome.
Kartalija M; Kaye K; Tureen JH; Liu Q; Täuber MG; Elliott BR; Sande MA
J Infect Dis; 1996 May; 173(5):1216-21. PubMed ID: 8627075
[TBL] [Abstract][Full Text] [Related]
15. Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance.
Hope W; Stone NRH; Johnson A; McEntee L; Farrington N; Santoro-Castelazo A; Liu X; Lucaci A; Hughes M; Oliver JD; Giamberardino C; Mfinanga S; Harrison TS; Perfect JR; Bicanic T
mBio; 2019 Dec; 10(6):. PubMed ID: 31796539
[TBL] [Abstract][Full Text] [Related]
16. [Cryptococcal meningoencephalitis in an immunocompetent patient caused by late onset exacerbation].
Numahata K; Akaiwa Y; Yoshizawa K; Norimine S; Onoue H; Miyamoto T
Rinsho Shinkeigaku; 2019 Apr; 59(4):190-194. PubMed ID: 30930365
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of intrathecal administration of liposomal amphotericin B combined with voriconazole in a murine model of cryptococcal meningitis.
Gazzoni AF; Capilla J; Mayayo E; Guarro J
Int J Antimicrob Agents; 2012 Mar; 39(3):223-7. PubMed ID: 22226648
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamics of liposomal amphotericin B and flucytosine for cryptococcal meningoencephalitis: safe and effective regimens for immunocompromised patients.
O'Connor L; Livermore J; Sharp AD; Goodwin J; Gregson L; Howard SJ; Felton TW; Schwartz JA; Neely MN; Harrison TS; Perfect JR; Hope WW
J Infect Dis; 2013 Jul; 208(2):351-61. PubMed ID: 23599314
[TBL] [Abstract][Full Text] [Related]
19. Voriconazole: a novel treatment option for cryptococcal meningitis.
Yao Y; Zhang JT; Yan B; Gao T; Xing XW; Tian CL; Huang XS; Yu SY
Infect Dis (Lond); 2015; 47(10):694-700. PubMed ID: 26100526
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B.
Pitisuttithum P; Tansuphasawadikul S; Simpson AJ; Howe PA; White NJ
J Infect; 2001 Nov; 43(4):226-33. PubMed ID: 11869059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
